- Report
- October 2024
- 150 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- September 2025
- 141 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- June 2025
- 141 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- May 2025
- 134 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- April 2025
- 143 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- April 2025
- 135 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- April 2025
- 148 Pages
Global
From €2661EUR$2,999USD£2,312GBP
- Report
- May 2025
- 120 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- March 2025
- 120 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- January 2025
- 130 Pages
Global
From €5280EUR$5,950USD£4,587GBP
- Report
- January 2025
- 163 Pages
Global
From €2653EUR$2,990USD£2,305GBP
- Report
- October 2025
- 193 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 190 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 189 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 186 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 181 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 182 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 196 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 190 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP
- Report
- October 2025
- 192 Pages
Global
From €3146EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,037GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more